Profile
Thomas Klaue currently works at INJEX Pharma AG, as Chief Executive Officer from 2013 and Siqens GmbH, as Chief Executive Officer from 2022.
Dr. Klaue also formerly worked at MediGene AG, as Chief Financial Officer.
Thomas Klaue active positions
| Companies | Position | Start |
|---|---|---|
INJEX Pharma AG
INJEX Pharma AG Medical SpecialtiesHealth Technology Manufactures needle free injection equipment | Chief Executive Officer | 30/06/2013 |
Siqens GmbH
Siqens GmbH Electronic Production EquipmentElectronic Technology Provides methanol fuel cells and electrochemical hydrogen capture technologies | Chief Executive Officer | 01/07/2022 |
Former positions of Thomas Klaue
| Companies | Position | End |
|---|---|---|
| MEDIGENE AG | Director of Finance/CFO | 19/04/2010 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
MediGene AG
MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
INJEX Pharma AG
INJEX Pharma AG Medical SpecialtiesHealth Technology Manufactures needle free injection equipment | Health Technology |
Siqens GmbH
Siqens GmbH Electronic Production EquipmentElectronic Technology Provides methanol fuel cells and electrochemical hydrogen capture technologies | Electronic Technology |
- Stock Market
- Insiders
- Thomas Klaue
















